Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2018 | The future of classifying and diagnosing dementia: a perspective

Johannes Attems • 20 Mar 2018
ARUK 2018
Alzheimer’s Disease Dementia

Methods to enable the early diagnosis of dementia are greatly needed. In this interview, Johannes Attems, MD, of Newcastle University, Newcastle, UK, discusses the classification of dementia and neuropathology, as well as his insights into potential diagnostic methods and hopes for the future of dementia diagnosis. This video was recorded at the Alzheimer’s Research UK (ARUK) Conference 2018, held in London, UK.

More from Johannes Attems

The differentiation between Lewy body and Parkinson's disease dementia
5:25
The differentiation between Lewy body and Parkinson's disease dementia
Johannes Attems • 19 Mar 2019
Unmets needs in Lewy body dementia: the neuropathologist's perspective
2:42
Unmets needs in Lewy body dementia: the neuropathologist's perspective
Johannes Attems • 19 Mar 2019
The pathology of neurodegeneration: an overview
3:52
The pathology of neurodegeneration: an overview
Johannes Attems • 20 Mar 2018
Quantitative neuropathological assessment to investigate the multi-morbid old brain
2:27
Quantitative neuropathological assessment to investigate the multi-morbid old brain
Johannes Attems • 20 Mar 2018

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
2:44
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
Jacqui Cannon • 5 Aug 2026
The Lewy Body Society's mission and impact
2:38
The Lewy Body Society's mission and impact
Jacqui Cannon • 5 Aug 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals